Cleveland Clinic’s 2026 immunodeficiency symposium examines the diagnostic and treatment challenges of inborn errors of immunity across several specialties. The program moves from antibody deficiencies and hematologic complications to cellular immune defects, complex presentations, and treatment options. Sessions address CVID, APDS, diagnostic vaccination, recurrent infections, immunoglobulin replacement, and transplantation, alongside discussion of artificial intelligence in clinical practice. Case presentations and panels connect these subjects with the difficulties clinicians encounter when assessing immunocompromised patients. This review is relevant to allergy and immunology professionals and colleagues involved in multidisciplinary immune care. The original agenda below retains the session sequence, timings, and faculty.
Original meeting: September 18–19, 2026, at the InterContinental Hotel & Conference Center in Cleveland, Ohio, with in-person and livestream options. Course director: James Fernandez, MD, PhD.
Package scope: The agenda describes the original educational program, including breaks and discussion periods; it does not establish the exact inventory or completeness of the supplied files. Provider registration, live attendance, publisher-platform access, accounts, memberships, apps, and publisher-hosted extras are not included.
Learning Objectives
After completing the original educational activity, participants should be better able to:
- Provide an update on common variable immunodeficiency syndrome and research on IgE levels in immunodeficiency.
- Describe advances in specific antibody deficiency and utilize vaccine testing guidelines.
- Summarize recent advancements in identifying and treating hematologic complications, including chronic neutropenia and immune thrombocytopenia.
- Discuss the increased cancer risks in immunocompromised patients and their implications for cancer screening.
- Review the clinical presentation, pathogenesis, diagnosis, and treatment of various immune disorders caused by cellular defects.
- Recognize, assess, and diagnose common symptoms seen in immunocompromised patients to help improve patient outcomes through earlier diagnosis.
- Define uses of artificial intelligence to improve and individualize therapy in patients with immune dysfunction.
- Critically appraise innovations in immunoglobulin replacement therapy, gene therapy, and stem cell transplantation in the treatment of immunodeficiency syndromes.
- Summarize the efficacy, side effects, and clinical implications of therapeutic options in management strategies for patients with complex immunodeficiency diseases.
Topics and Program
Friday, September 18, 2026
|
|
|
7:15 am
|
Registration, Breakfast and Visit Exhibits |
|
7:50 am
|
Welcome & Introductions James Fernandez, MD, PhD |
Session 1 – Humoral Deficiency
|
|
|
8:00 am
|
CVID – the latest Charlotte Cunningham-Rundles, MD, PhD |
|
8:30 am
|
CVID like syndromes – APDS and beyond Jocelyn Farmer, MD, PhD |
|
9:00 am
|
Updates in Specific Antibody Deficiency and Diagnostic Vaccination Guidelines Kelli Williams, MD, MPH |
|
9:30 am
|
IgE levels – what does it tell us? Monica Lawrence, MD |
|
10:00 am
|
Panel Discussion Course Faculty |
|
10:20 am
|
Refreshment Break & Visit Exhibits |
Session 2 – Hematologic Complications
|
|
|
10:40 am
|
Chronic Neutropenia – how to handle Serhan Unlu, MD |
|
11:10 am
|
ITP in immune disease Alan Lichtin, MD |
|
11:40 am
|
Cancer in Immunodeficiency – screening recommendations John McDonnell, MD, MS |
|
12:10 pm
|
Panel Discussion Course Faculty |
|
12:30 pm
|
Lunch, Visit Exhibits, and Optional Non-CME Satellite |
Session 3 – Cellular Defects
|
|
|
1:30 pm
|
Idiopathic CD4 Lymphocytopenia Jonathan Bernstein, MD |
|
2:00 pm
|
Job’s Syndrome and CMCC – a dermatologist’s view Anthony Fernandez, MD, PhD |
|
2:30 pm
|
Mendelian Susceptibility to Mycobacterial Disease Vivian Hernandez-Trujillo, MD |
|
3:00 pm
|
Chronic Granulomatous Disease in adults (including X-linked) Antoine Azar, MD |
|
3:20 pm
|
Panel Discussion Course Faculty |
|
3:40 pm
|
Refreshment Break and Visit Exhibits |
Session 4 – Complex Disease and Future Options
|
|
|
4:00 pm
|
Thinking outside the box: diagnostic immunology evaluation of the complex immunology patient Roshini Abraham, PhD, D(ABMLI) |
|
4:30 pm
|
Using Artificial Intelligence to your advantage in practice Nicholas Rider, DO |
|
5:00 pm
|
Biologics use in the immunocompromised Jolan Walter, MD, PhD |
|
5:30 pm
|
Panel Discussion Course Faculty |
|
5:45 pm
|
Adjourn Reception and Optional Non-CME Satellite |



